FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF-23 signaling and regulating FGF-23 expression in bone-Reference-Cited by-同舟云学术

FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF-23 signaling and regulating FGF-23 expression in bone

Published:2011-09-21 Issue:10 Volume:26 Page:2486-2497
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Wöhrle Simon,Bonny Olivier,Beluch Noemie,Gaulis Swann,Stamm Christelle,Scheibler Marcel,Müller Matthias,Kinzel Bernd,Thuery Anne,Brueggen Joseph,Hynes Nancy E,Sellers William R,Hofmann Francesco,Graus-Porta Diana

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jbmr.478/fullpdf

Reference61 articles.

1. The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis;Razzaque;Nat Rev Endocrinol.,2009

2. Endocrine FGFs and Klothos: emerging concepts;Kuro-o;Trends Endocrinol Metab.,2008

3. Cellular signaling by fibroblast growth factor receptors;Eswarakumar;Cytokine Growth Factor Rev.,2005

4. Overview of the FGF23-Klotho axis;Kuro-o;Pediatr Nephrol.,2010

5. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23;The ADHR Consortium;Nat Genet.,2000

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Highly Potent and Selective Covalent FGFR4 Inhibitors Based on S_NAr Electrophiles;Journal of Medicinal Chemistry;2024-04-11

2. Fibroblast Growth Factor Receptor Inhibitors Decrease Proliferation of Melanoma Cell Lines and Their Activity Is Modulated by Vitamin D;International Journal of Molecular Sciences;2024-02-21

3. Safety Profile and Adverse Event Management for Futibatinib, An Irreversible FGFR1–4 Inhibitor: Pooled Safety Analysis of 469 Patients;Clinical Cancer Research;2024-02-08

4. Promising results of a clinical feasibility study: CIRBP as a potential biomarker in pediatric cardiac surgery;Frontiers in Cardiovascular Medicine;2024-02-01

5. Clinical development and management of adverse events associated with FGFR inhibitors;Cell Reports Medicine;2023-10